2018 Q3 Form 10-Q Financial Statement

#000155198618000009 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q2

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.110M $10.66M $40.00K
YoY Change 4670.59% 26550.0% -73.33%
Cash & Equivalents $8.112M $10.66M $5.023K
Short-Term Investments
Other Short-Term Assets $530.0K $240.0K $330.0K
YoY Change 103.85% -27.27% 560.0%
Inventory $610.0K
Prepaid Expenses
Receivables $210.0K
Other Receivables $0.00
Total Short-Term Assets $8.637M $10.91M $1.190M
YoY Change 714.84% 816.62% -47.65%
LONG-TERM ASSETS
Property, Plant & Equipment $40.23K $45.37K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.580K $5.580K $10.00K
YoY Change -44.2% -44.2% -99.15%
Total Long-Term Assets $45.81K $50.95K $2.360M
YoY Change -98.03% -97.84% -35.36%
TOTAL ASSETS
Total Short-Term Assets $8.637M $10.91M $1.190M
Total Long-Term Assets $45.81K $50.95K $2.360M
Total Assets $8.683M $10.96M $3.550M
YoY Change 156.14% 208.7% -40.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.883M $3.348M $599.0K
YoY Change 364.98% 458.87% -59.14%
Accrued Expenses $229.4K $0.00 $1.416M
YoY Change -84.81% -100.0% -60.97%
Deferred Revenue
YoY Change
Short-Term Debt $5.190M $4.150M $380.0K
YoY Change 276.09% 992.11% -91.93%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.302M $7.500M $3.763M
YoY Change 70.13% 99.3% -69.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.302M $7.500M $3.763M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $8.300M $7.500M $3.760M
YoY Change 70.08% 99.47% -69.1%
SHAREHOLDERS EQUITY
Retained Earnings -$39.30M -$38.53M -$35.97M
YoY Change 7.12% 24.04%
Common Stock $2.598K $2.570K $1.000K
YoY Change 157.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $380.8K $3.459M -$213.0K
YoY Change
Total Liabilities & Shareholders Equity $8.683M $10.96M $3.550M
YoY Change 156.14% 208.7% -40.07%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Areas of the financial statements where estimates may have the most significant effect include accrued expenses, share-based compensation, deferred compensation, valuation allowance for income tax assets and management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern. Changes in the facts or circumstances underlying these estimates could result in material changes and actual results could differ from these estimates.</font></div></div>
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001551986
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25787437 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
INNOVATE BIOPHARMACEUTICALS, INC.
dei Trading Symbol
TradingSymbol
INNT
innt Adjustments To Additional Paid In Capital Warrant Issued To Placement Agents
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToPlacementAgents
913000 USD
innt Adjustments To Additional Paid In Capital Warrant Issued To Placement Agents
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToPlacementAgents
913000 USD
CY2018Q2 innt Capital Stock Authorized
CapitalStockAuthorized
360000000 shares
innt Convertible Promissory Notesbeneficial Conversion Feature
ConvertiblePromissoryNotesbeneficialConversionFeature
0 USD
innt Convertible Promissory Notesbeneficial Conversion Feature
ConvertiblePromissoryNotesbeneficialConversionFeature
3077887 USD
CY2018Q1 innt Exchange Ratio In Connection With Merger
ExchangeRatioInConnectionWithMerger
0.37686604
CY2016 innt Milestone Fee Free Sales Target Value
MilestoneFeeFreeSalesTargetValue
1500000000 USD
innt Net Proceeds From Issuance Of Common Stock After Deducting Stock Issuance Costs
NetProceedsFromIssuanceOfCommonStockAfterDeductingStockIssuanceCosts
16500000 USD
innt Number Of Warrants Issued
NumberOfWarrantsIssued
1400000 shares
innt Payments To Executives
PaymentsToExecutives
145000 USD
CY2017Q4 innt Operating Lease Annual Rental Payments
OperatingLeaseAnnualRentalPayments
5000 USD
CY2017Q4 innt Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
60000 USD
innt Payment Of Deferred Debt Issuance Cost
PaymentOfDeferredDebtIssuanceCost
0 USD
innt Payment Of Deferred Debt Issuance Cost
PaymentOfDeferredDebtIssuanceCost
159795 USD
CY2017 innt Payment Of Stock Subscription Receivable
PaymentOfStockSubscriptionReceivable
25 USD
CY2018Q1 innt Payments To Executives
PaymentsToExecutives
1100000 USD
innt Placement Agent Fees
PlacementAgentFees
1600000 USD
innt Proceeds From Rececived Of Payment Of Stock Subscription Receivable
ProceedsFromRececivedOfPaymentOfStockSubscriptionReceivable
25 USD
innt Proceeds From Rececived Of Payment Of Stock Subscription Receivable
ProceedsFromRececivedOfPaymentOfStockSubscriptionReceivable
0 USD
innt Proceeds From Shortterm Convertible Debt
ProceedsFromShorttermConvertibleDebt
1700000 USD
innt Proceeds From Shortterm Convertible Debt
ProceedsFromShorttermConvertibleDebt
345000 USD
innt Receivable For Warrants Exercised
ReceivableForWarrantsExercised
0 USD
innt Receivable For Warrants Exercised
ReceivableForWarrantsExercised
12472 USD
innt Repayments Of Shortterm Convertible Debt
RepaymentsOfShorttermConvertibleDebt
0 USD
innt Repayments Of Shortterm Convertible Debt
RepaymentsOfShorttermConvertibleDebt
275000 USD
innt Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
-978674 USD
innt Warrant Term
WarrantTerm
P5Y
innt Warrants Issued To Placement Agents
WarrantsIssuedToPlacementAgents
0 USD
innt Warrants Issued To Placement Agents
WarrantsIssuedToPlacementAgents
913000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2658637 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3347614 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1180225 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7167189 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43181593 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3077887 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6018732 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8186000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2568079 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2000000 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1995000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1085700 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3472900 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-184000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8186000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20142 USD
CY2018Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
700000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1171985 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1200000 USD
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6509824 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6509824 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8476377 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8476377 shares
CY2017Q4 us-gaap Assets
Assets
798489 USD
CY2018Q2 us-gaap Assets
Assets
10958775 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
752202 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
10907824 USD
CY2017Q4 us-gaap Cash
Cash
355563 USD
CY2018Q2 us-gaap Cash
Cash
10663434 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
360811 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5023 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
355563 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10663434 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-355788 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10307871 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11888240 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25695602 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11888240 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25695602 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11888 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
2570 USD
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
8329045 USD
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
159795 USD
CY2018Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
us-gaap Depreciation
Depreciation
1674 USD
us-gaap Depreciation
Depreciation
9279 USD
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
75000 USD
CY2018Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.87
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1065225 USD
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8500000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.0
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.848
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.025
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1561106 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4141832 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2132850 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8299463 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2790322 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6778198 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4215552 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-839481 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20371296 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
564255 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-289697 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
524246 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1020430 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10220 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
70074 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
99483 USD
us-gaap Interest Expense
InterestExpense
171130 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
894118 USD
us-gaap Interest Expense
InterestExpense
4555737 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
150988 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
25578 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
280287 USD
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
560380 USD
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
54637 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
85129 USD
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-09-30
CY2017Q4 us-gaap Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
P2Y
CY2017Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P3Y
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
798489 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10958775 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
978674 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12973103 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7499599 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1700025 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19527582 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1600 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
61057 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2054213 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9280768 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-2790322 USD
us-gaap Net Income Loss
NetIncomeLoss
-6778198 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-11605817 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4215552 USD
us-gaap Net Income Loss
NetIncomeLoss
-20371296 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-99483 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-171130 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1495284 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4470608 USD
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2018Q2 us-gaap Notes Payable Current
NotesPayableCurrent
4151985 USD
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
244816 USD
CY2018Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2690839 USD
us-gaap Operating Expenses
OperatingExpenses
6607068 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3376071 USD
us-gaap Operating Expenses
OperatingExpenses
15900688 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2690839 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6607068 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3376071 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15900688 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
115000 USD
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5580 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5580 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
20000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1600 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13943 USD
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
161844 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
244390 USD
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
0 USD
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
75000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18132661 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18100000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40707 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45371 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1129733 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2465236 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1243221 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7601225 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19353691 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39724987 USD
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
5000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3472900 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8186000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.53
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
119438461 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5396755 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.44
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
140355814 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6366229 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.52
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.08
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
414719 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.60
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6617433 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
141694679 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6843296 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6428577 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y0M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y1M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M23D
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
9229336 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
9229819 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16137661 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12472 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-6587554 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-12174614 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
3459176 USD
CY2018Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one new share for every ten shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11888240 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11888240 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25695171 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23481834 shares

Files In Submission

Name View Source Status
0001551986-18-000009-index-headers.html Edgar Link pending
0001551986-18-000009-index.html Edgar Link pending
0001551986-18-000009.txt Edgar Link pending
0001551986-18-000009-xbrl.zip Edgar Link pending
ex311q22018.htm Edgar Link pending
ex312q22018.htm Edgar Link pending
ex321q22018.htm Edgar Link pending
ex322q22018.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
innt-20180630.xml Edgar Link completed
innt-20180630.xsd Edgar Link pending
innt-20180630_cal.xml Edgar Link unprocessable
innt-20180630_def.xml Edgar Link unprocessable
innt-20180630_lab.xml Edgar Link unprocessable
innt-20180630_pre.xml Edgar Link unprocessable
innt630201810q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending